D&T Subcommittee Meeting Bil. 01/2019

posted Apr 15, 2019, 11:48 PM by Chong Ching Wern   [ updated Apr 15, 2019, 11:48 PM ]

No.

Drug Name

Decision

1)

Rufinamide 200mg Tablet

(Inovelon)

Agreed to accept as Special Formulary (upon request).

2)

Yellow Fever Vaccine Injection

(Stamaril)

Agree to accept as Special Formulary (non-claimable).

3)

Dapagliflozin 10mg Tablet

(Forxiga)

Rejected to add Cardiologists as prescriber, to maintain current restriction.

4)

Baricitinib 4mg Tablet

(Olumiant)

Rejected as Special Formulary.

Availability of Tofacitinib 5mg Tablet in the UMMC formulary.

Suggest to apply to use using BUK on named patient basis.

5)

Esomeprazole 20mg MUPS Tablet

Esomeprazole 40mg MUPS Tablet

Multiple Unit Pellet System

(Nexium / Axiago)

Agree to accept as Standard Formulary to replace Omeprazole 2mg/mL Syrup.

6)

Aripiprazole 400mg Prolonged Release Injection

(Abilify Maintena)

Agree to accept as Special Formulary.

7)

Liothyronine 100mcg Injection

Agree to delete from the UMMC formulary.

Availability of Levothyroxine 200mcg Injection in the UMMC formulary.

8)

Polymixin B Neomycin Hydrocortisone Ear Drops

(Pocin)

Agree to delete from the UMMC formulary.

Ototoxicity due to Neomycin component and removal from APPL contract list.

9)

Varenicline 1mg Tablet

(Champix)

Agree to delete from the UMMC formulary.

Closure of Smoking Cessation Clinic, no prescriptions seen since 2016, slow movement and easily available in community pharmacies.

10)

Varenicline 0.5mg Tablets x 11

Varenicline 1mg Tablets x 14

(Champix Starter Pack)

Agree to delete from the UMMC formulary.

Closure of Smoking Cessation Clinic, no prescriptions seen since 2016, slow movement and easily available in community pharmacies.

11)

Clodronate Sodium 800mg Tablet

(Bonefos)

Agree to delete from the UMMC formulary.

Company discontinuation.

12)

Isotretinoin 10mg Capsule

(Roaccutane)

Rejected to delete from the UMMC formulary, to maintain current restriction.

13)

Isotretinoin 20mg Capsule

(Roaccutane)

Rejected to delete from the UMMC formulary, to maintain current restriction.

14)

Dulaglutide 0.75mg Injection

Dulaglutide 1.5mg Injection

(Trulicity)

Pending press release on cardiovascular safety outcome trial in June 2019.

Costs more than existing agents available in the UMMC formulary.

Suggest to review pricing.



Disclaimer:

For new drug request, physical stock availability will depend on procurement processes.

Tender items will take about 3-6 months, non tender items will take about 1-3 months.

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.